Heres whats coming soon, and whats in clinical trials: Orforglipron (brand name Foundayo): A once-daily oral GLP-1 was just approved by the FDA for weight loss, and will hopefully be approved for type 2 diabetes soon
Ashleigh, T., Swerdlow, R
For mycotoxin exposure from mold or heavy metal accumulation , glutathione is particularly effective, binding to harmful substances for elimination through urine and bile
[PMID: 41797384] PubMed record related to this compound for laboratory literature review
Abstract Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management
Fees A 3.00% closing fee and a 2.00% exit fee, each calculated on the total revolving commitments, along with a $375,000 arranger fee